Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 2Obesity 1

Interventions

Cyclophosphamide 1499Cisplatin 1434Paclitaxel 1339Radiotherapy 1310Carboplatin 1266Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 697Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Orlistat × Clear all
NCT01003483 2021-04-01

Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients

Yazd Research & Clinical Center for Infertility

Phase 2 Completed
80 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT00704912 2016-11-07

OWL-PCOS

Milton S. Hershey Medical Center

Phase 2 Completed
217 enrolled 16 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡